Rotigotine transdermal patch

( DrugBank: Rotigotine / KEGG DRUG: Rotigotine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	72

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 72 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-000867-65-DE (EUCTR)	19/04/2021	16/03/2021	Investigation of the adhesion properties of a newly developed rotigotine-containing patchin patients ...	Comparative, randomized, open, crossover clinical trial to investigate adhesiveness of a newly devel ...	Idiopathic Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: ROT-TDS 8 mg/24 h INN or Proposed INN: ROTIGOTINE Trade Name: Neupro® 8 mg/24 h Product N ...	Luye Pharma Switzerland AG	NULL	Not Recruiting			Female: yes Male: yes	38	Phase 2	Germany
2	NCT04384666 (ClinicalTrials.gov)	June 2, 2020	8/5/2020	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of RotigotineAfte ...	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of RotigotineAfte ...	Parkinson Disease	Drug: LY03003 (rotigotineextended release microspheres for intramuscular [IM] injection);Other: Neup ...	Luye Pharma Group Ltd.	NULL	Completed	18 Years	45 Years	All	56	Phase 1	United States
3	NCT04183634 (ClinicalTrials.gov)	December 3, 2019	28/11/2019	An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Tra ...	An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Tra ...	Parkinson Disease	Drug: Rotigotine TTS (Test);Drug: Neupro (Reference)	Sandoz	NULL	Terminated	18 Years	80 Years	All	31	Phase 1	Germany
4	JPRN-JapicCTI-194763	22/4/2019	20/05/2019	Safety and PK study of LY03003	An open-label study in Japanese patients with Parkinson's disease to evaluate the safety, pharmacoki ...	Parkinson's Disease	Intervention name : Rotigotine INN of the intervention : Rotigotine Dosage And administration of the i ...	Shandong Luye Pharmaceutical Co., Ltd./CMIC Co., Ltd.	NULL	complete	20		BOTH	32	Phase 1	Japan
5	NCT03733561 (ClinicalTrials.gov)	November 9, 2018	6/11/2018	A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro	A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of RotigotineAfte ...	Parkinson Disease	Drug: LY03003;Drug: Neupro 4Mg/24Hr Transdermal Patch	Luye Pharma Group Ltd.	NULL	Completed	18 Years	45 Years	All	40	Phase 1	United States
6	JPRN-UMIN000033409	2018/07/30	17/07/2018	Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomi ...	Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomi ...	Parkinson's disease	Pretreatment by heparinoid In the pretreatment group, heparinoid is applied daily to the sites (shoul ...	Wakayama Medical University	NULL	Complete: follow-up complete	20years-old	85years-old	Male and Female	20	Phase 1	Japan
7	NCT02365870 (ClinicalTrials.gov)	August 2016	11/2/2015	Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment	Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment	Anxiety Disorders;Parkinson Disease	Drug: rotigotine transdermal patch;Drug: placebo	Johns Hopkins University	National Institute on Aging (NIA)	Terminated	21 Years	89 Years	All	4	Phase 4	United States
8	EUCTR2014-000335-17-GB (EUCTR)	28/10/2014	23/07/2014	Rotigotine and memory in Parkinson's.	The Effect of Rotigotineon Memory in Idiopathic Parkinson's Disease without Cognitive Impairment - R ...	Idiopathic Parkinson's Disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: rotigotine INN or Proposed INN: Rotigotine Product Name: levodopa CR (controlled release ...	Research and Development University Hospital of North Staffordshire	Keele University	Not Recruiting			Female: yes Male: yes	0		United Kingdom
9	EUCTR2012-002840-26-RO (EUCTR)	12/11/2013	17/07/2014	Study to test the efficacy of two doses of Rotigotineon depressive mood (apathy) associated with Par ...	A Multicenter, Multinational, Double-blind, Placebo-controlled, 3-arm Phase 4 Study to Evaluate the ...	Parkinson's disease MedDRA version: 17.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Trade Name: Neupro Product Name: Rotigotine INN or Proposed INN: ROTIGOTINE Trade Name: Neupro Product N ...	UCB Biosciences GmbH	NULL	Not Recruiting			Female: yes Male: yes	504	Phase 4	Serbia;United States;Slovakia;Slovenia;Spain;Ukraine;Turkey;Austria;Italy;Hungary;Poland;Romania;Cro ...
10	EUCTR2013-000827-15-IT (EUCTR)	11/05/2013	15/03/2013	LATE ONSET PARKINSON’S DISEASE IN SUBJECTS 70 YEARS AND OLDER: POSSIBLE USE OF ROTIGOTINE	LATE ONSET PARKINSON’S DISEASE IN SUBJECTS 70 YEARS AND OLDER: POSSIBLE USE OF ROTIGOTINE - PARROT	Parkinson disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: Rotigotine Product Name: neurpro Product Code: SPM962	Unità Malattie Neurodegenerative, Ospedale Cardinale Giovanni Panico, Tricase	NULL	Not Recruiting			Female: yes Male: yes			Italy

First Previous1 2 3 4 5…8Next Last